P8IP
MDT icon

Pier 88 Investment Partners’s Medtronic MDT Stock Holding History

Pier 88 Investment Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.88M Buy
33,200
+2,800
+9% +$268K 0.72% 29
2025
Q4 		$2.92M Buy
+30,400
New +$2.95M 0.65% 29

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pier 88 Investment Partners's MDT Position: Q1 2026 in Review

Pier 88 Investment Partners increased its Medtronic (MDT) stake by 9.2% in Q1 2026, buying an estimated $268K and bringing the position to 33,200 shares worth $2.88M. The position accounts for 0.72% of the portfolio, ranked #29.

Pier 88 Investment Partners first reported a position in MDT in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.92M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Pier 88 Investment Partners held 33,200 shares of Medtronic worth $2.88M as of Q1 2026.
  • Pier 88 Investment Partners bought 2,800 Medtronic shares in Q1 2026, an estimated $268K.
  • Medtronic made up 0.72% of Pier 88 Investment Partners's portfolio in Q1 2026, its #29 holding.
  • Pier 88 Investment Partners first reported a position in Medtronic in Q4 2025 and has held it in 2 quarters since.
  • Pier 88 Investment Partners's Medtronic position peaked at $2.92M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Pier 88 Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.